Photobiomodulation therapy in age-related macular degeneration
- Resource Type
- Authors
- Justin Muste; Rishi P Singh; Carolina C. S. Valentim; Aneesha Kalur; Amogh Iyer
- Source
- Current Opinion in Ophthalmology. 32:225-232
- Subject
- medicine.medical_specialty
genetic structures
business.industry
MEDLINE
General Medicine
Macular degeneration
medicine.disease
eye diseases
Pupil
Ophthalmology
Geographic Atrophy
Age related
Wet Macular Degeneration
medicine
Humans
sense organs
Limited evidence
Low-Level Light Therapy
business
- Language
- ISSN
- 1531-7021
1040-8738
Purpose of review To review the available data supporting the use of photobiomodulation therapy (PBT) in the treatment of age-related macular degeneration (AMD). Recent findings PBT might be used in treating nonexudative AMD. Limited evidence suggests that exudative AMD may also benefit from PBT. Summary The optimal device would deliver doses of 60 J/cm2 or more with a multiwavelength composition through the pupil over short treatment intervals. Safe upper limits have not been established. More studies are needed to evaluate the efficacy of PBT in treating exudative and nonexudative AMD.